We developed a new apparatus, the virtual gland (VG), for measuring the rate of fluid secretion (J v 
INTRODUCTION
People with the genetic disease cystic fibrosis (CF) typically die from unremitting lung infections. Susceptibility to these infections is generally considered to arise from dysfunction of electrolyte and fluid transport across airway epithelia. Transport dysfunction is caused by loss of function of CFTR, an anion channel found primarily in the apical membranes of epithelial cells.
Both ciliated surface epithelia and submucosal gland serous cells express CFTR, and both of these cell types presumably contribute to the etiology of CF airway disease, but glands are the major secretory organs of healthy lungs. When provoked, they produce copious amounts of antibiotic-rich mucus that traps pathogens and inhibits their growth while they are swept from the airways (28) . Mucus clearance normally keeps the airways sterile, and it has been proposed that altered gland function in CF airways impairs the mucus shield (1, 15-17, 21, 23, 26, 49, 52, 54) .
Airway glands can be studied in isolation and a great deal has been learned about their regulation (42) . Gland mucus secretion has been quantified extensively (1, 6, 15-17, 23, 25, 26, 38, 47-50) , but because glands are difficult to study with electrophysiological methods, electrophysiological study of cultured monolayers of gland cells and cell lines has mainly been used (31, (55) (56) (57) (58) . However, except in rare cases (22, 45) fluid transport by cell sheets has not been quantified. Therefore, we sought a simple method that would help bridge the gap between studies of native glands and cultured cell sheets.
We have now developed a novel method for measuring fluid secretion across epithelial cell sheets, and have used it to quantify the amount and selected features of fluid secretion by Calu-3 cells, a widely studied surrogate for airway submucosal gland serous cells (39) . Our method differs in several respects from prior studies of J v in airway epithelia (22, 45) . In the best of these, Miller et al. used an elegant modification of the capacitance probe technique (51) to measure fluid absorption across the retinal pigment epithelium with an accuracy of 0.5-1.0 nl/min (34) , and subsequently their method was used to clarify important points of transport in several systems (5, 10, 37) , including gland cells from normal and CF subjects (22) . In the capacitance probe apparatus the epithelial cell sheet separates two large volumes (~12 ml) of fluid. The chambers are sealed except for a single thin column of fluid that moves relative to a probe that detects the capacitance between it and the surface of the fluid. The advantages of the capacitance probe are its sensitivity and ability to measure fluid flow in either direction. A Page 4 of 37 disadvantage is that the large volumes of fluid used essentially clamp the fluid composition, so that, unlike the natural situation, the cells do not determine the composition of their apical fluid.
The large volumes also mean the composition of the secreted fluid is unknown.
The apparatus introduced here, which we term a 'Virtual Gland', is advantageous for studies of secretory epithelia because it allows the formation and collection of the secreted fluid. The virtual gland has about the same sensitivity as the capacitance probe, is simpler to use, and because the bath is an open system, secretion rates are not altered by variations in the height, volume, or temperature-related volume changes of the bath. In addition to being able to measure the composition of the secreted fluid, this system has the additional advantage that the cells can respond to that fluid, as we expect they do in real glands. The ionic concentration of the secreted fluid will help set the apical transmembrane potential, and secreted mediators, for example ATP (8) , can act back on the cells to influence the secretory process.
In the present studies we introduce the VG method and use it to provide direct evidence that (4, 31, 36, 39) .
We determined the magnitude and properties of Calu-3 fluid secretion in response to various mediators and inhibitors, and compared the results with predictions made from I SC studies (4, 11-14, 18, 19, 27, 30-32, 35, 36, 39, 40, 43, 44, 53) , and with secretion by native airway submucosal glands (21, (23) (24) (25) (26) 54) . growing area, Costar, Cambridge, MA) that had been coated with human placental collagen (Sigma). Cells were grown at the air/liquid interface for at least 14 days before use. In the present study, the mean age of the cells was 21 ± 1 days (n=70).
METHODS

Cell culture
Virtual gland apparatus The prototype virtual gland (VG) is shown in Fig. 1 . A Costar
Snapwell filter containing confluent cells is assembled as shown so that a 1.7 mm thick plastic barrier creates a small volume apical chamber above the apical surface of the cells. The barrier separates a thin film (~90 µm depth, ~10 µl) of apical fluid from a water-saturated mineral oil layer (500 µl). A 0.6 mm diameter hole in the barrier serves as a virtual duct to convey the apical fluid into the oil-filled collection chamber, where it forms a spherical bubble whose diameter can be measured optically at regular intervals and converted to a volume; the change in volume over time provides a direct measure of J v (see below). A second smaller hole serves as a voltage port (see below).
Before assembly the apical surface of the cells is rinsed 2X with Krebs-Ringer bicarbonate buffer (KRB) without glucose and then 2X with the same solution containing 10 µM Blue Dextran. The filter cup and the collection chamber are then both filled with the blue dextran solution and the collection chamber is pressed gently but firmly into the Snapwell filter cup while the filter is supported against a flat, KRB-covered surface to prevent it from being distended by the pressure of assembly. Excess apical fluid is expressed through the hole into the collection chamber, and the purpose of having fluid of the same composition in that chamber at this stage is to prevent the formation of bubbles in the apical chamber which can otherwise occur during assembly. Because of variations in dimensions of the filters, cell layers and assembly procedures, assembled VGs have apical chambers of variable volumes, which thus must be measured in each experiment.
To estimate the volume of the apical chamber, the bubble of apical fluid is collected at intervals during secretion and the blue dextran concentration [BD] determined colorimetrically.
The apical chamber volume is then given by:
Where:
V A = volume of apical chamber V SF = volume of secreted fluid
[BD] SF = blue dextran concentration in the collected fluid bubble
[BD] initial = starting concentration of blue dextran (initially 10 µM, and then reset after each measurement).
In the present study, the estimated mean volume of the apical chamber was 10.0 ± 1.0 µl (n=60).
The assembled Snapwell filter and collection chamber is placed in a fabricated plastic bath holder so that the cell layer is positioned just at the surface of the bath KRB solution (volume ~5 ml) to eliminate any significant positive or negative hydrostatic pressure. Reagents Forskolin, thapsigargin, acetazolamide, bumetanide and ouabain were obtained from Sigma. 1-Ethyl-2-benzimidazolinone (1-EBIO) was purchased from Aldrich Chem. Co.
(Milwaukee, WI). Ouabain was dissolved in deionized water at a stock concentration of 10 mM.
A 10 mM stock solution of bumetanide was made by dissolving in 200 mM sodium hydroxide.
All other drugs were dissolved in dimethylsulfoxide (DMSO) at the following concentrations:
forskolin, 10 mM or 50 mM, thapsigargin, 1 mM, acetazolamide, 200 mM, 1-EBIO, 2 M and glibenclamide, 300 mM. In control experiments we observed that DMSO levels >0.15%, depressed basal J v , so we kept the final concentration of DMSO at or below 0.15% where possible.
Statistics All data are expressed as means ± SEM, and n indicates the number of experiments. Statistical difference was determined by Student's t test. A value of p<0.05 was considered statistically significant.
RESULTS
Basal secretion
Filters mounted in the virtual gland showed high and variable rates of fluid secretion immediately after mounting, but declined to relatively stable values within 30-60 min.
Therefore, we ignored the first 60 min of data and followed basal secretion for up to 6 additional hours. Summary data for four long-term basal secretion experiments is shown in Fig. 3 , and mean basal secretion rates for a much larger sample taken 60-90 min post-mounting are shown in increased TEP from -7.6 ± 0.8 to -12.1 ± 1.2 mV (59 ± 16%, n = 10, (Fig. 4) . VIP (1 µM) increased J v from 3.1 ± 0.4 to 5.4 ± 0.8 µl/cm 2 /hr (71 ± 25%, n=4, data not shown).
Thapsigargin (333 nM) increased J v from 2.0 ± 0.2 to 6.4 ± 0.9 µl/cm 2 /hr (213 ± 44 %, n=5) and increased the average TEP from -8.2 ± 1.2 to -18.2 ± 3.3 mV (122 ± 40%, n=5, Fig. 4, 5) . In some experiments we noted oscillations in the TEP as has been reported for the I SC after stimulation with thapsigargin ( Fig. 1g) Bumetanide inhibits the Na + -K + -2Cl -cotransporter (NKCC), which is responsible for transporting Cl -into the cell across the basolateral membrane. To estimate the contribution of NKCC-dependent Cl -secretion to J v and TEP, we tested the effects of bumetanide (10 µM) on basal and stimulated secretion. Bumetanide reduced basal J v from 2.5 ± 0.3 to 2.1 ± 0.3 µl/cm 2 /hr (18 ± 11 %) and TEP and from -9.2 ± 0.6 to -5.8 ± 1.1 mV (37 ± 11 %, n=5, Fig. 6 ).
The response to forskolin was not affected by bumetanide, but the response to thapsigargin was eliminated: addition of thapsigargin after bumetanide failed to increase either J v 2.1 ± 0.3 to 2.2 ± 0.5 µl/cm 2 /hr (3 ± 22 %) or TEP -5.8 ± 1.1 to -6.9 ± 1.7 mV, (20 ± 30 % (n = 5, data not shown). When bumetanide was applied following thapsigargin stimulation it inhibited almost 100% of the stimulated J v and TEP (n=5, Fig. 5 ).
When bumetanide followed 1-EBIO stimulation, it had differential effects on J v and TEP. Bumetanide inhibited most but not all of the J v , leaving J v ~ 35% higher than basal values. In contrast, the TEP was inhibited to a level 65% below the basal value (n=5, data not shown). We have no explanation for this unusual effect. Because of the large response to forskolin + thapsigargin, we were interested to see the effect of bumetanide on these agents used in combination. Bumetanide reduced the J v from 11.6 ± 1.1 to 6.8 ± 0.7 µl/cm 2 /hr (-42 ± 6%, n=5) and the TEP from 21.3 ± 4.1 to 9.7 ± 1.7 mV (-55 ± 8%, n=5). We noted that the J v remaining after bumetanide was significantly (p < 0.001) greater than the basal value of 2.0 ± 0.5 µl/cm 2 /hr, suggesting that, in the presence of forskolin, thapsigargin can slightly increase the secretion of a bumetanide-insensitive component, which is most likely HCO 3 -.
Acetazolamide, which inhibits carbonic anhydrase, was previously shown to reduce the basal I SC of Calu-3 cells by ~ 1/3 (44) . In the virtual gland, acetazolamide (100 µM) reduced basal J v from 2.3 ± 0.2 to 1.6 ± 0.3 µl/cm 2 /hr (29 ± 11 %) and TEP from -8.2 ± 1.1 to -6.7 ± 1.1 mV (18 ± 14 %, n=5, Fig. 6 ). Stimulation by forskolin (5 µM) was blocked after acetazolamide:
neither J v nor TEP showed a significant increased J v = 10 ± 20 % and TEP = 10 ± 10% (n = 5, n.s. data not shown). (n=4), but the TEP was only reduced from -7.7 ± 0.9 to -4.8 ± 1.1 mV (37 ± 14 %, n=5, Fig. 6 and Fig. 8 ). Additional ouabain reduced the TEP to zero mV within 60 additional min (data not shown).
HEPES (HCO
Glibenclamide is a non-specific inhibitor of CFTR (41) . Addition of 600 µM glibenclamide basolaterally reduced the basal J v and TEP by 49 and 46%, to 1.8 ± 0.3 µl/cm 2 /hr and -6.8 ± 1.9 mV (n = 4). Addition of forskolin after glibenclamide produced no increase in either J v or TEP (n=3), but subsequent addition of thapsigargin caused a 98% increase in J v to 2.7 ± 0.5 µl/cm 2 /hr (n=4). However, this occurred in the presence of a decrease in TEP (mean change of -21% to -4.5 ± 0.5 mV). The J v changes to thapsigargin + forskolin were highly variable in the presence of glibenclamide, ranging from zero to 284%, and the maximum J v observed was only 3.6 µl/cm 2 /hr, vs. a mean J v of ~ 12 µl/cm 2 /hr observed in the absence of glibenclamide. In 3 experiments glibenclamide was added after forskolin and the mean result was to reduce J v back to basal levels. Note that for maximum effectiveness glibenclamide is usually added bilaterally, but was only added basolaterally in these experiments.
Relationship between mean J v and mean TEP in the Virtual Gland. The transepithelial potential difference ranged from zero to -38 mV, and showed an approximately monotonic relation to Jv, with each 2.8 mV of TEP equating to a J v of ~ 1 µl/cm 2 /hr (Fig. 9) . If secretion is purely isotonic (150 mM) 1 µl/cm 2 /hr should correspond to ~4 µA, which would give a mean resistance for the filters of 700 • cm 2 .
The peak J v in response to every agonist was always delayed relative to the peak TEP and 
Comparison of Calu-3 responses in VG with Calu-3 I SC responses and native gland secretion
A comparison of responses to agonists for Calu-3 cells in the VG vs. in the Ussing chamber is shown in Table 1 which also includes the response for these same agonists observed in native glands. Note that agonists and antagonists can only be added basolaterally in the VG and for real glands. The J v and I SC responses were qualitatively similar, while the main difference in comparison to glands is that thapsigargin had little effect on native glands, while carbachol has little effect on Calu-3 cells. If Calu-3 cell responses to thapsigargin are compared to gland responses to carbachol, it is seen that responses to carbachol and forskolin are completely occlusive in glands, whereas they are additive and possibly synergistic in Calu-3 cells. We hypothesize that activation of muscarinic receptors in glands can't be mimicked merely by
[ Thapsigargin increased J v to 6.4 µl/cm 2 /hr, and this increase was completely eliminated by prior treatment with bumetanide, consistent with the increased J v being mediated by Cl -secretion.
However, the pH of fluid stimulated by thapsigargin was 7.23, which suggests that HCO 3 -secretion was not eliminated, but simply became a smaller fraction of anion secretion.
Combined J v response to forskolin + thapsigargin The largest increases in J v were produced by combining these two agonists, which gave a mean J v of 12.2 µl/cm 2 /hr. This combined response was inhibited 42% by bumetanide and 64% by HCO 3 -replacement with HEPES, and the combination entirely eliminated the response. The pH of fluid secreted in response to these two agonists was 7.4 (23 mM HCO 3 -). The interpretation of these results is not direct because of the possibility that inhibition of one anion transport pathway leads to compensatory increases in the other, but given the pH measure, it appears that this condition also represents a combination of HCO 3 -and Cl -mediated fluid secretion.
What is the status of CFTR in these conditions? Ussing chamber (36) and patch clamp (7) data suggest that CFTR is the only apical anion channel in Calu-3 cells. The presence of basal secretion and the ability of thapsigargin to stimulate secretion are consistent with CFTR being active in the basal state. However, because forskolin alone stimulated secretion and greatly augmented thapsigargin-stimulated secretion, one of two things must be true: (i) CFTR nPo is rate limiting for secretion and not fully active at rest; or (ii) forskolin must stimulate other transport pathways that contribute to J v .
The pH (HCO 3 -concentration) of secreted fluid To summarize the results across all conditions (Fig. 10) , the estimated [HCO 3 -] of the secreted fluid was higher than bath for forskolin or VIP stimulation, but was close to bath values during basal secretion and secretion stimulated by thapsigargin alone or in combination with forskolin. These results vary from expectations that forskolin or VIP-mediated secretion will be mediated by nearly pure HCO 3 -secretion and thapsigargin-stimulated secretion by nearly pure Cl -secretion (4). We hypothesize that the lower than predicted levels of HCO 3 -detected in basal and forskolin-stimulated conditions occurs because of parallel secretion of acid that neutralizes some of the HCO 3 - (29) . We further hypothesize that the higher than predicted levels of HCO 3 -observed during thapsigargin- In a typical tubule, the outer diameter is ~60 µm, lumen diameter is ~20 µm, and cell height is ~20 µm (Fig. 12a,b) . One way to pose the geometric issues in glands and VG is to consider apical fluid volume relative to cell volume or surface area. Using the observed gland tubule dimensions to calculate volumes (considering tubules as cylinders) shows that the epithelial cell volume for a given length of tubule is ~ 8 times the resting lumen volume (this ratio will increase at the ends of the tubules and of course approaches infinity as the lumen volume approaches zero). In our present experiments, the mean estimated apical volume in the VG experiments was times greater than in the VG.
The conclusion from these considerations is that our apparatus, while achieving a 300-fold improvement over a 3 ml Ussing chamber, nevertheless causes a considerable dilution of the serous cell secretions in comparison with real glands. 
Conclusions
